Abyholm G, Monn E
Eur J Pediatr. 1979 Mar 1;130(3):149-54. doi: 10.1007/BF00455260.
Intranasal administration of DDAVP (1-deamino-8-D-arginine vasopressin), a synthetic analogue of vasopressin, followed by measurement of urine osmolaity 6 h afterwards, represents a convenient, reliable and simple method for the estimation of renal concentrating capacity in children. The DDAVP-test is as accurate and reproducible as the water deprivation test, irrespective of the degree of concentrating capacity. Mean urine osmolality after DDAVP in children without renal disease was found to be 984 +/- 218 mosmol/kg water (m +/- 2 SD). In children with recurrent pyelonephritis, urine osmolality after DDAVP was decreased. The values were significantly lower with bilateral changes than with unilateral changes of chronic pyelonephritis in the i.v. urograms. In chronic pyelonephritis the concentrating capacity appears to be earlier impaired than other parameters of renal function.
经鼻给予去氨加压素(1-去氨基-8-D-精氨酸加压素),它是加压素的一种合成类似物,随后在6小时后测量尿渗透压,这是一种评估儿童肾脏浓缩功能的简便、可靠且简单的方法。去氨加压素试验与禁水试验一样准确且可重复,与浓缩功能的程度无关。发现无肾脏疾病儿童在给予去氨加压素后的平均尿渗透压为984±218毫摩尔/千克水(平均值±2标准差)。在复发性肾盂肾炎患儿中,给予去氨加压素后的尿渗透压降低。在静脉肾盂造影中,双侧改变时的值显著低于慢性肾盂肾炎单侧改变时的值。在慢性肾盂肾炎中,浓缩功能似乎比肾功能的其他参数更早受损。